Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
74 Leser
Artikel bewerten:
(1)

Medigene AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution

Medigene AG / Medigene AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Medigene AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution

X Notification of Major Holdings 

or

 Correction of a notification of Major Holding published on   (date of publication)

1. Details of issuer (name, address)

Medigene AG

Lochhamer Str. 11

82152 Planegg/Martinsried

Germany

2. Reason for notification (multiple reasons possible)

 Acquisition/disposal of shares with voting rights

 Acquisition/disposal of instruments

 Change of breakdown of voting rights

X Other reason: Restatement of interest in line with Transparency Directive amendments, also § 41 Abs. 4f WpHG

3. Details of person subject to the notification obligation

Name:

Aviva plc
City and country of registered office (if applicable):

London, United Kingdom
   

4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.

Aviva Life & Pensions UK Ltd.

5. Date on which threshold was crossed or reached: 26.11.2015

6. Total positions
  % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments
(total of 7.b.1 + 7.b.2)
total of both in % (7.a. + 7.b.) total number of voting rights of issuer
Resulting situation 7.63% 2.21% 9.84% 19,678,221
Previous notification (if applicable) 9.72% N/A% N/A%  




7. Notified details of the resulting situation
a. Voting rights attached to shares (Sec.s 21, 22 WpHG)
ISIN absolute in %
direct

(Sec. 21 WpHG)
indirect

(Sec. 22 WpHG)
direct

(Sec. 21 WpHG)
indirect

(Sec. 22 WpHG)
DE000A1X3W00 0 1502268 0% 7.63%
       %  %
Total 1502268 7.63%

b.1. Instruments according to Sec. 25 Abs. 1 Nr. 1 WpHG (please use annex in case of more than 3 instruments)
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
RIGHT TO RECALL LOANED SHARES N/A N/A 433837 2.21%
         %
         %
    Total 433837 2.21%

b.2 Instruments according to Sec. 25 Abs. 1 Nr. 2 WpHG (please use annex in case of more than 3 instruments)
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
           %
           %
           %
      Total    %

8. Information in relation to the person subject to the notification obligation (please tick the applicable box):

 

 Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).

 

 X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity (please use annex in case of more than 4 undertakings; in this case please always provide only to BaFin also an organizational chart accompanying your notification):

 
Name % of voting rights
(if at least held 3% or more)
% of voting rights through instruments
(if at least held 5% or more)
Total of both
(if at least held 5% or more)
See annex  %  %  %
   %  %  %
   %  %  %
   %  %  %

9. In case of proxy voting according to § 22 Abs. 3 WpHG

Date of general meeting:  

Holding position after general meeting:   % (equals   voting rights)

Attachment to (please tick the applicable box)

 II.7.b.1. (fill in the sums into the standard form)

7.b.1. Instrumente i.S.d. Sec. 25 para. 1 No. 1 WpHG (attachment can be extended)
Type of instrument Voting rights absolute Voting rights in % Expiration or maturity date Exercise or conversion period
     %    
     %    
     %    
     %    
     %    
     %    

 II.7.b.2. (fill in the sums into the standard form)

7.b.2. Instrumente i.S.d. Sec. 25 Abs. 1 No. 2 WpHG (attachment can be extended)
Type of instrument Voting rights absolute Voting rights in % Expiration or maturity date Exercise or conversion period Cash or physical settlement
     %      
     %      
     %      
     %      
     %      
     %      

 X II.8. (Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity; attachment can be extended)

Name % of voting rights

(if at least held 3% or more)
% of voting rights through instruments

(if at least held 5% or more)
Total of both

(if at least held 5% or more)
Aviva plc  %  %  %
Aviva Group Holdings Ltd  %  %  %
Aviva Participations SA  %  %  %
Aviva France SA  %  %  %
   %  %  %
Aviva plc  %  %  %
Aviva Group Holdings Ltd  %  %  %
Aviva Life Holdings UK Ltd  %  %  %
Aviva Life & Pensions UK Ltd 5.34%  % 7.36%
   %  %  %
Aviva plc  %  %  %
Aviva Group Holdings Ltd  %  %  %
Aviva Investors Holdings Ltd  %  %  %
Aviva Investors Luxembourg SA  %  %  %
   %  %  %
Aviva plc  %  %  %
Aviva Group Holdings Ltd  %  %  %
Aviva Investors Holdings Ltd  %  %  %
Aviva Investors Global Services Ltd  %  %  %
Aviva Investors Investment Funds

ICVC
 %  %  %
   %  %  %
Aviva plc  %  %  %
Aviva Group Holdings Ltd  %  %  %
Aviva Investors Holdings Ltd  %  %  %
Aviva Investors Global Services Ltd  %  %  %
Aviva Investors International Fund  %  %  %

Planegg-Martinsried, 22.01.2016

The Executive Management Board

Contact Medigene AG
Public & Investor Relations
Julia Hofmann / Dr. Robert Mayer
Email: investor@medigene.com
Tel.: ++49 - 89 - 20 00 33 33 01




This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Medigene AG via Globenewswire

HUG#1980955

--- End of Message ---

Medigene AG
Lochhamer Strasse 11 Martinsried / München Germany

WKN: A1X3W0;ISIN: DE000A1X3W00;
Listed: Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
Freiverkehr in Börse Berlin,
Freiverkehr in Börse Düsseldorf,
Freiverkehr in Bayerische Börse München,
Freiverkehr in Niedersächsische Börse zu Hannover,
Prime Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse;


Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2016 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.